Registered number
15090763
KAI PHARMA LIMITED
Filleted Accounts
31 August 2025
KAI PHARMA LIMITED
Registered number: 15090763
Balance Sheet
as at 31 August 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 3 640 800
Current assets
Debtors 4 - 1,000
Cash at bank and in hand 455 1,028
455 2,028
Creditors: amounts falling due within one year 5 (291) (1,727)
Net current assets 164 301
Net assets 804 1,101
Capital and reserves
Called up share capital 1 1
Profit and loss account 803 1,100
Shareholders' funds 804 1,101
Number Number
Average no of employees 1 1
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Karwan Ibrahim
Director
Approved by the board on 15 December 2025
KAI PHARMA LIMITED 15090763 false 2024-09-01 2025-08-31 2025-08-31 VT Final Accounts April 2025 Karwan Ibrahim No description of principal activity 15090763 core:WithinOneYear 2024-08-31 15090763 core:ShareCapital 2024-08-31 15090763 core:RetainedEarningsAccumulatedLosses 2024-08-31 15090763 2024-09-01 2025-08-31 15090763 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15090763 bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 15090763 bus:Director40 2024-09-01 2025-08-31 15090763 bus:FRS102 2024-09-01 2025-08-31 15090763 bus:FilletedAccounts 2024-09-01 2025-08-31 15090763 2025-08-31 15090763 core:WithinOneYear 2025-08-31 15090763 core:ShareCapital 2025-08-31 15090763 core:RetainedEarningsAccumulatedLosses 2025-08-31 15090763 2024-08-31 iso4217:GBP xbrli:pure